Skip to main content
DAEWON PHARMACEUTICAL CO.,LTD logo

DAEWON PHARMACEUTICAL CO.,LTD — Investor Relations & Filings

Ticker · 003220 ISIN · KR7003220001 KO Manufacturing
Open in API
Filings indexed 300 across all filing types
Latest filing 2025-02-20 Notice of Dividend Amou…
Country KR South Korea
Listing KO 003220

About DAEWON PHARMACEUTICAL CO.,LTD

https://www.daewonpharm.com/eng

Daewon Pharmaceutical Co., Ltd., established in 1958, is a pharmaceutical company focused on improving human health. The company specializes in the development and manufacturing of prescription drugs and finished pharmaceutical products. Its portfolio includes a range of medications such as antipyretics, analgesics, and treatments for respiratory and cardiovascular conditions. Daewon Pharmaceutical maintains a strong commitment to research and development, with a strategic focus on New Chemical Entities (NCE) and Incrementally Modified Drugs (IMD) to provide advanced healthcare solutions.

Recent filings

Filing Released Lang Actions
현금ㆍ현물배당결정
Notice of Dividend Amount Classification · 100% confidence The document is a formal announcement from Daewon Pharmaceutical regarding the decision to pay cash dividends. It specifies the dividend amount per share, the total dividend amount, the record date, and the date of the board resolution. This aligns perfectly with the definition of a 'Notice of Dividend Amount' (DIV).
2025-02-20 Korean
주식등의대량보유상황보고서(약식)
Major Shareholding Notification Classification · 100% confidence The document is a 'Report of Large Shareholding' (주식등의 대량보유상황보고서) filed by Fidelity Management & Research Company LLC regarding their holdings in Daewon Pharmaceutical Co., Ltd. This type of filing is a standard regulatory requirement for institutional investors when they cross specific ownership thresholds in a publicly traded company. In the context of the provided categories, this falls under 'Major Shareholding Notification' (MRQ).
2025-02-17 Korean
매출액또는손익구조30%(대규모법인은15%)이상변경
Earnings Release Classification · 95% confidence The document is a regulatory filing from Daewon Pharmaceutical regarding a significant change in sales or profit/loss structure (30% or more). It provides preliminary financial results (revenue, operating profit, net income) for the current fiscal year compared to the previous year. This type of disclosure is a standard preliminary earnings announcement required by the Korea Exchange (KRX) for listed companies, which falls under the 'Earnings Release' category as it provides key financial highlights before the final audited annual report is published. FY 2024
2025-02-07 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed with the Financial Supervisory Service in South Korea. This type of filing is specifically used to disclose shareholdings and changes in ownership by company insiders (directors/executives). In the provided taxonomy, this corresponds to 'Director's Dealing' (DIRS), which covers insider transactions and ownership reporting.
2025-01-07 Korean
주주명부폐쇄기간또는기준일설정
Notice of Dividend Amount Classification · 95% confidence The document is a short regulatory announcement from Daewon Pharmaceutical regarding the setting of a record date for the upcoming 64th Annual General Meeting. It is a standard corporate disclosure regarding shareholder rights and meeting preparation, which falls under general regulatory announcements as it does not contain the full proxy materials or the meeting presentation itself.
2024-12-16 Korean
분기보고서 (2024.09)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (분기보고서) for Daewon Pharmaceutical Co., Ltd. for the period ending September 30, 2024. It contains detailed financial data, business operations, management discussion, and corporate governance information. As it is a comprehensive financial report for a period shorter than a full fiscal year, it falls under the 'Interim / Quarterly Report' category. 9M 2024
2024-11-14 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.